Table 2.

Quantitative Results (SARS-CoV-2 RNA copies per milliliter).

Patient	TW	NS	OS	SA
1	$8.4\times {10}^4$	$2.9\times {10}^7$	$7.3\times {10}^5$	NA
2	$3.6\times {10}^5$	$1.7\times {10}^2$	$3.8\times {10}^4$	NA
3	$2.4\times {10}^2$	$6.8\times {10}^4$	$1.1\times {10}^3$	NA
4	$1.7\times {10}^8$	$1.5\times {10}^6$	$2.6\times {10}^4$	NA
5	0	0	0	$3.4\times {10}^3$
6	$3.2\times {10}^2$	$8.1\times {10}^2$	$9.5\times {10}^5$	NA
7	$3.7\times {10}^3$	$9.7\times {10}^4$	$1.6\times {10}^4$	NA
8	$7.6\times {10}^1$	$4.0\times {10}^6$	$2.3\times {10}^4$	NA
9	$3.0\times {10}^4$	$1.7\times {10}^7$	$2.1\times {10}^7$	NA
10	$1.2\times {10}^4$	$2.2\times {10}^4$	$1.3\times {10}^4$	NA
11	$1.7\times {10}^4$	$7.7\times {10}^5$	$1.1\times {10}^5$	NA
12	$1.5\times {10}^3$	$3.5\times {10}^2$	0	NA
13	$9.8\times {10}^2$	$1.3\times {10}^4$	$1.2\times {10}^3$	$4.4\times {10}^3$
14	$2.7\times {10}^3$	$5.5\times {10}^5$	$3.4\times {10}^5$	$4.7\times {10}^3$
15	$2.1\times {10}^4$	$2.2\times {10}^5$	$1.5\times {10}^5$	$5.3\times {10}^4$
16	$7.2\times {10}^3$	$2.6\times {10}^2$	$6.1\times {10}^2$	$5.0\times {10}^2$
17	$2.6\times {10}^3$	0	$1.0\times {10}^4$	$3.5\times {10}^4$
18	0	$4.1\times {10}^3$	0	0
19	$8.9\times {10}^3$	$2.5\times {10}^3$	0	$1.7\times {10}^3$
20	$1.8\times {10}^5$	$1.1\times {10}^7$	$1.3\times {10}^6$	$4.3\times {10}^4$
21	$8.4\times {10}^7$	$2.8\times {10}^7$	$1.2\times {10}^8$	NA
22	$1.3\times {10}^3$	$4.0\times {10}^3$	$7.3\times {10}^3$	0
23	$2.0\times {10}^2$	0	0	$3.5\times {10}^3$
24	$3.3\times {10}^3$	$4.8\times {10}^4$	$1.1\times {10}^4$	$4.1\times {10}^2$
25	$4.8\times {10}^5$	$6.0\times {10}^6$	$4.6\times {10}^4$	$9.9\times {10}^4$
26	0	0	$1.3\times {10}^3$	0
27	0	0	0	0
28	$1.1\times {10}^6$	$3.2\times {10}^7$	$5.7\times {10}^6$	$8.3\times {10}^3$
29	$7.3\times {10}^4$	$1.5\times {10}^7$	$3.2\times {10}^5$	$1.3\times {10}^3$
30	$7.9\times {10}^5$	$3.1\times {10}^5$	$4.6\times {10}^5$	$6.3\times {10}^5$
31	$5.3\times {10}^4$	$1.4\times {10}^3$	$2.3\times {10}^3$	$2.3\times {10}^6$
32	0	$1.2\times {10}^3$	0	0
33	$4.3\times {10}^2$	$5.8\times {10}^6$	$2.0\times {10}^5$	$1.1\times {10}^3$
34	$4.9\times {10}^3$	$1.7\times {10}^6$	$1.2\times {10}^3$	NA
Sensitivity a	85%	85%	79%	76%
Summary b	Median $4.3\times {10}^3$	Median $5.8\times {10}^4$	Median $1.4\times {10}^4$	Median $3.4\times {10}^3$
	IQR $3.5\times {10}^2$ – $6.8\times {10}^4$	IQR $9.1\times {10}^2$ – $3.4\times {10}^6$	IQR $1.1\times {10}^3$ – $2.9\times {10}^5$	IQR $4.1\times {10}^2$ – $3.5\times {10}^4$

^a Diagnostic sensitivity calculated as proportion of subjects with a positive test result among the total number of subjects analyzed. ^b Statistical data in the summary line are shown as median and interquartile ranges (IQR). Abbreviations: NA, not available; NS, nasopharyngeal swab; OS, oropharyngeal swab; SA, saliva; SARS-CoV-2, severe acute respiratory syndrome coronavirus 2; TW, throat wash.